Vyripharm Enterprises, L.L.C. — Form D

Vyripharm Enterprises, L.L.C. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2016-08-08. The offering totals $2.3M. Industry: Biotechnology.

Offering

• Filed: 2016-08-08
• Form: D
• Accession: 0001079973-16-001097
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $2.3M
• Remaining: $2.3M
• Minimum investment: $50K
• Security types: equity, debt
• Revenue range: No Revenues
• SEC file number: 021-268519

Issuer

• Name: Vyripharm Enterprises, L.L.C.
• CIK: 0001681739
• Entity type: Limited Liability Company
• Jurisdiction: DELAWARE
• Incorporated: 2014
• Address: 2450 Holcombe Blvd., HOUSTON, TX, 77021
• Phone: 713-357-1045

Officers, directors & promoters (2)

More

• CIK 1681739 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search